Hepatitis C virus-associated glomerulonephritis

Contributions to Nephrology

Volumn 181, Issue , 2013, Pages 194-206

  Tang, Sydney C W ^a   Lai, Kar Neng ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ARTICLE; CRYOGLOBULINEMIA; GLOMERULONEPHRITIS; HEPATITIS C; HUMAN; PATHOLOGY; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; GLOMERULONEPHRITIS; HEPATITIS C; HUMANS; VIRUS REPLICATION;

EID: 84879072255     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000348477     Document Type: Article

References (36)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-362. (Pubitemid 19117877)
2. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N: Cryoglobulinemia-a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966; 40:837-856.
3. Robertson B, Myers G, Howard C, Brettin T, Bukh J, Gaschen B, Gojobori T, Maertens G, Mizokami M, Nainan O, Netesov S, Nishioka K, Shin-i T, Simmonds P, Smith D, Stuyver L, Weiner A: Classification, nomenclature, and database development for hepatitis C virus and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 1998; 143:2493-2503. (Pubitemid 29022697)
4. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizo-kami M, Murphy DG, Okamoto H, Paw-lotsky JM, Penin F, Sablon E, Shin I, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A: Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42:962-973. (Pubitemid 41401136)
5. Chevaliez S, Pawlotsky JM: Virology of hepatitis C virus infection. Best Pract Res Clin Gastroenterol 2012; 26:381-389.
6. Poynard T, Yuen MF, Ratziu V, Lai CL: Viral hepatitis C. Lancet 2003; 362:2095-2100. (Pubitemid 38035201)
7. Seto WK, Lai CL, Fung J, Hung I, Yuen J, Young J, Wong DK, Yuen MF: Natural history of chronic hepatitis C: genotype 1 versus genotype 6. J Hepatol 2010; 53:444-448.
8. Krahn M, Wong JB, Heathcote J, Scully L, Seeff L: Estimating the prognosis of hepatitis C patients infected by transfusion in Canada between 1986 and 1990. Med Decis Making 2004; 24:20-29. (Pubitemid 38116854)
9. Maasoumy B, Wedemeyer H: Natural history of acute and chronic hepatitis C. Best Pract Res Clin Gastroenterol 2012; 26:401-412.
10. Perico N, Cattaneo D, Bikbov B, Remuzzi G: Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 2009; 4:207-220.
11. Wornle M, Schmid H, Banas B, Merkle M, Henger A, Roeder M, Blattner S, Bock E, Kretzler M, Grone HJ, Schlondorff D: Novel role of toll-like receptor 3 in hepatitis C-asso-ciated glomerulonephritis. Am J Pathol 2006; 168:370-385. (Pubitemid 43271137)
12. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE: Membranoprolifera-tive glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328:465-470. (Pubitemid 23056436)
13. Tsui JI, Vittinghoff E, Shlipak MG, O'Hare AM: Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2006; 17: 1168-1174.
14. Huang JF, Chuang WL, Dai CY, Ho CK, Hwang SJ, Chen SC, Lin ZY, Wang LY, Chang WY, Yu ML: Viral hepatitis and pro-teinuria in an area endemic for hepatitis B and C infections: another chain of link? J Intern Med 2006; 260:255-262.
15. Li CG, Ferrantelli A, Bono L, Tortorici C, Giammarresi C, Zagarrigo C, Schillaci O, Tralongo A, Soresi M, Rotolo U: Incidence of hepatitis C virus infection in patients with chronic kidney disease on conservative therapy. Int J Infect Dis 2011; 15:e514-e516.
16. Lai FM, Tam JS, Liew CT, Ip M, Lai KN: Low prevalence of hepatitis C virus antibodies with primary membranous nephropathy and membranoproliferative glomerulonephritis in Hong Kong. Nephron 1995; 70:367-368.
17. D'Amico G: Renal involvement in hepatitis C infection: cryoglobulinemic glomerulone-phritis. Kidney Int 1998; 54:650-671. (Pubitemid 28357431)
18. KDIGO Clinical Practice Guidelines for the Prevention, Diagnosis, Evaluation and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int 2008; 73(suppl 109):S69-S77.
19. Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F: Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997; 25:1237-1244. (Pubitemid 27199954)
20. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH: Hepatitis C and renal disease: an update. Am J Kidney Dis 2003; 42:631-657. (Pubitemid 37187365)
21. Bartenschlager R, Cosset FL, Lohmann V: Hepatitis C virus replication cycle. J Hepatol 2010; 53:583-585.
22. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeu-zem S, Trepo C, Albrecht J: Randomised trial of interferon-α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon-α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 1998; 352:1426-1432. (Pubitemid 28510876)
23. Tang S, Cheng IK, Leung VK, Kuok UI, Tang AW, Ho YW, Lai KN, Chan TM: Successful treatment of hepatitis C after kidney transplantation with combined interferon-α2b and ribavirin. J Hepatol 2003; 39:875-878. (Pubitemid 37372201)
24. Zuckerman E, Keren D, Slobodin G, Rosner I, Rozenbaum M, Toubi E, Sabo E, Tsykou-nov I, Naschitz JE, Yeshurun D: Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavi-rin and interferon-α. J Rheumatol 2000; 27: 2172-2178.
25. Zeuzem S, Feinman SV, Rasenack J, Heath-cote EJ, Lai MY, Gane E, O'Grady J, Reichen J, Diago M, Lin A, Hoffman J, Brunda MJ: Peginterferon-α2a in patients with chronic hepatitis C. N Engl J Med 2000; 343:1666-1672.
26. Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB: An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54:1433-1444.
27. Sabry AA, Sobh MA, Sheaashaa HA, Kudesia G, Wild G, Fox S, Wagner BE, Irving WL, Grabowska A, El-Nahas AM: Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy. Nephrol Dial Transplant 2002; 17:1924-1930. (Pubitemid 35277089)
28. Alric L, Plaisier E, Thebault S, Peron JM, Rostaing L, Pourrat J, Ronco P, Piette JC, Cacoub P: Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 2004; 43:617-623. (Pubitemid 38401876)
29. Sansonno D, De Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F: Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon-α with an anti-CD20. Blood 2003; 101:3818-3826. (Pubitemid 36857852)
30. Saadoun D, Resche RM, Sene D, Terrier B, Karras A, Perard L, Schoindre Y, Coppere B, Blanc F, Musset L, Piette JC, Rosenzwajg M, Cacoub P: Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C-related mixed cryo-globulinemia. Blood 2010; 116:326-334.
31. Quartuccio L, Soardo G, Romano G, Zaja F, Scott CA, De Marchi G, Fabris M, Ferraccioli G, De Vita S: Rituximab treatment for glo-merulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology (Oxford) 2006; 45:842-846. (Pubitemid 43985372)
32. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J: Peginterferon-α2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347:975-982.
33. Vermehren J, Sarrazin C: New HCV therapies on the horizon. Clin Microbiol Infect 2011; 17:122-134.
34. Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem S: Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011; 364:2405-2416.
35. Dumortier J, Guillaud O, Gagnieu MC, Janbon B, Juillard L, Morelon E, Leroy V: Antiviral triple therapy with telaprevir in haemo-dialysed HCV patients: Is it feasible? J Clin Virol 2013; 56:146-149.
36. Lai KN, Tang SC: Hepatitis-associated glo-merulonephritis; in Lerma EV, Berns JS, Nis-senson AR (eds): Current Diagnosis and Treatment in Nephrology and Hypertension. New York, McGraw-Hill, 2009, p 302.